WEBULL
News
SCNI
0.7035
-6.20%
-0.0465
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 2d ago
Scinai Immunotherapeutics Shareholders Approve Share Increase, Equity Grants and Auditor at December 22 Meeting
TipRanks · 4d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 6d ago
Weekly Report: what happened at SCNI last week (1215-1219)?
Weekly Report · 6d ago
Weekly Report: what happened at SCNI last week (1208-1212)?
Weekly Report · 12/15 09:07
Weekly Report: what happened at SCNI last week (1201-1205)?
Weekly Report · 12/08 09:07
Scinai Immunotherapeutics Reports Growth and Pipeline Progress
TipRanks · 12/03 03:52
Scinai Immunotherapeutics Reports Nine-Month 2025 Results and Strategic Developments
TipRanks · 12/02 16:27
Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
PR Newswire · 12/02 13:50
Weekly Report: what happened at SCNI last week (1124-1128)?
Weekly Report · 12/01 09:06
Weekly Report: what happened at SCNI last week (1117-1121)?
Weekly Report · 11/24 09:07
Weekly Report: what happened at SCNI last week (1110-1114)?
Weekly Report · 11/17 09:07
Scinai Immunotherapeutics Announces December 2025 Shareholder Meeting
TipRanks · 11/13 22:41
Scinai Immunotherapeutics Announces Board Changes and New Accounting Firm Amid Cost-Cutting Efforts
TipRanks · 11/13 22:26
Weekly Report: what happened at SCNI last week (1103-1107)?
Weekly Report · 11/10 09:07
Weekly Report: what happened at SCNI last week (1027-1031)?
Weekly Report · 11/03 09:07
Weekly Report: what happened at SCNI last week (1020-1024)?
Weekly Report · 10/27 09:07
Weekly Report: what happened at SCNI last week (1013-1017)?
Weekly Report · 10/20 09:07
Weekly Report: what happened at SCNI last week (1006-1010)?
Weekly Report · 10/13 09:07
Scinai Immunotherapeutics Secures Grant to Boost CDMO Capabilities
TipRanks · 10/06 12:20
More
Webull provides a variety of real-time SCNI stock news. You can receive the latest news about Scinai Immunotherapeutics Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.